Bei Ya raised Broadcom's target price from $195.00 to $210.00.COMEX silver fell 2.00% in the day and is now quoted at $30.99 per ounce. COMEX silver fell to $31 per ounce, down 1.97% in the day.Analysis: the potential weakness of Canada's manufacturing industry still exists. Forexlive: Canada's manufacturing industry rebounded strongly, mainly driven by petroleum products and automobiles. However, the year-on-year data decline shows that some potential weakness still exists.
Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.Domestic futures opened mixed at night, with Shanghai Gold down 0.57%, Shanghai Silver down more than 1%, Shanghai Zinc up 0.68%, thread down 0.5%, coking coal down 0.6%, glass down 1.22% and crude oil up nearly 1%.Market News: Brazilian President Lula performed well after the operation, and a new medical report is expected later today.
Guangzhou Institute: Make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. With the rapid development of polysilicon industry, the relationship between supply and demand changes rapidly and the price fluctuates greatly due to various factors such as industrial policy, production cycle and technological progress. Due to the lack of objective and continuous price signals, the polysilicon industry has concentrated capacity investment and construction, which is prone to problems such as staged supply and demand mismatch, which is not conducive to the healthy and stable development of the industry. In this context, photovoltaic industry chain enterprises have increasingly strong demands for listed polysilicon futures, pricing with futures tools and managing risks. At the same time, the listed polysilicon futures will help to export the international pricing benchmark, form the "China" price of polysilicon international trade reflecting China's industrial volume, and gradually enhance China's influence in polysilicon international trade pricing. The insiders believe that at present, the industrial silicon varieties in Guangzhou have been running smoothly for nearly two years, and the listing of polysilicon varieties will further improve the variety layout of the crystalline silicon industrial chain for futures services, and provide more accurate futures tools for polysilicon and its downstream photovoltaic industrial chain, which is conducive to further consolidating the global competitive advantage of China's photovoltaic and other industries. The relevant person in charge of the Guangzhou Stock Exchange said that in the next step, under the guidance of the China Securities Regulatory Commission, the Guangzhou Stock Exchange will make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. (Guangzhou Institute)Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, while Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, accounting for 0.58% of the total turnover of the day. The average transaction price was 255 yuan, which was 4.51% lower than the market closing price of 267.03 yuan, of which the highest transaction price was 267.03 yuan and the lowest transaction price was 218.97 yuan.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14